Regulatory FDA Expands AI Capabilities and Completes Data Platform Consolidation FDAFDA announced major steps in its bold initiative to modernize the agency.Read full story pharminent May 6, 2026 (Last updated: May 7, 2026) FDA FDA announced major steps in its bold initiative to modernize the agency. Read full story Post navigation Previous: Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipelineNext: Novo Nordisk Raises Guidance on Strong Wegovy Pill Launch Related Stories Regulatory FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit pharminent May 7, 2026 Regulatory Bayer plans filings for cardiac amyloidosis imaging agent pharminent May 7, 2026 Regulatory FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight pharminent May 6, 2026
